• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Stability of collapse lyophilized influenza vaccine formulations

tetano

Editor, Senior Moderator
Int J Pharm. 2015 Feb 6. pii: S0378-5173(15)00105-2. doi: 10.1016/j.ijpharm.2015.01.053. [Epub ahead of print]
[h=1]Stability of collapse lyophilized influenza vaccine formulations.[/h] Anamur C[SUP]1[/SUP], Winter G[SUP]1[/SUP], Engert J[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] A clear limitation of many liquid vaccines is the obligatory cold-chain distribution system. Therefore, distribution of a dried vaccine formulation may be beneficial in terms of vaccine stability, handling and transport. Collapse freeze-drying is a process which utilizes fairly aggressive but at the same time economic lyophilization cycles where the formulation is dried above its glass transition temperature. In this study, we used collapse freeze-drying for a thermosensitive model influenza vaccine (Pandemrix[SUP]?[/SUP]). The dried lyophilizates were further cryo-milled to engineer powder particles in the size range of approximately 20-80μm which is applicable for epidermal powder immunization. Vaccine potency and stability were neither affected by high temperature input during collapse lyophilization nor over a storage period of six months. Furthermore, cryo-milled vaccine lyophilizates showed good storage stability of up to three months at high storage temperature (40?C). This technique can provide a powerful tool for the worldwide distribution of vaccine and for new application technologies such as engineered powder immunization.
Copyright ? 2015. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] Collapse lyophilization; Cryo-milling; Influenza vaccine; Powder immunization; Vaccination

PMID: 25660049 [PubMed - as supplied by publisher]
 
Back
Top Bottom